The prevalence, patterns and impact of irritable bowel syndrome: an international survey of 40 000 subjects

@article{Hungin2003ThePP,
  title={The prevalence, patterns and impact of irritable bowel syndrome: an international survey of 40 000 subjects},
  author={A. Hungin and P. Whorwell and J. Tack and F. Mear{\'i}n},
  journal={Alimentary Pharmacology \& Therapeutics},
  year={2003},
  volume={17}
}
Aim : To determine the prevalence, symptom pattern and impact of the irritable bowel syndrome, across eight European countries, using a standardized methodology. 

Paper Mentions

Interventional Clinical Trial
Irritable bowel syndrome (IBS) is a gastrointestinal (GI) syndrome characterized by chronic abdominal pain and altered bowel habits in the absence of any organic cause. The symptoms of… Expand
ConditionsIrritable Bowel Syndrome With Constipation
InterventionDrug
Irritable bowel syndrome in the United States: prevalence, symptom patterns and impact
Background : The impact of irritable bowel syndrome, a gastrointestinal motility disorder, is underestimated and poorly quantified, as clinicians may see only a minority of sufferers.
Prevalence and demographics of irritable bowel syndrome: results from a large web‐based survey
TLDR
This work has shown clear trends in the prevalence and demographics of irritable bowel syndrome among women over the age of 40, and these trends have continued to improve since the 1970s. Expand
Prevalence of irritable bowel syndrome according to different diagnostic criteria in a non‐selected adult population
TLDR
Prevalence of irritable bowel syndrome shows great variation among epidemiological studies, which may be due to different diagnostic criteria, and should be considered as a cause for concern. Expand
Systematic review: the influence of geography and ethnicity in irritable bowel syndrome
  • J. Kang
  • Medicine
  • Alimentary pharmacology & therapeutics
  • 2005
TLDR
In some case series of irritable bowel syndrome from the Indian subcontinent and Africa, the female predominance typical of western patients did not occur. Expand
The epidemiology of irritable bowel syndrome: Symptom development over a 3‐year period in Denmark. A prospective, population‐based cohort study
TLDR
The natural history of irritable bowel syndrome in Denmark over 3 years was explored by studying development of IBS symptoms and associated factors. Expand
The economic impact of irritable bowel syndrome
Background : Although little mortality is associated with irritable bowel syndrome, curative therapy does not exist and thus the economic impact of this disorder may be considerable.
Systematic review: the efficacy of treatments for irritable bowel syndrome – a European perspective
Irritable bowel syndrome (IBS) is a common, chronic disorder, characterized by abdominal pain/discomfort, bloating and altered bowel habit.
Review article: the economic impact of the irritable bowel syndrome
TLDR
A large number of people worldwide have IBS, and it has substantial impact on patients' quality of life (QoL) and is associated with considerable healthcare resource use. Expand
Systematic review: the perceptions, diagnosis and management of irritable bowel syndrome in primary care – A Rome Foundation Working Team Report
TLDR
To review studies on the perceptions, diagnosis and management of irritable bowel syndrome (IBS) in primary care, a large number of studies from around the world have been reviewed. Expand
The complex interplay between gastrointestinal and psychiatric symptoms in irritable bowel syndrome: A longitudinal assessment
The aims of this study were to better define the relationship between irritable bowel syndrome (IBS) and psychiatric disorders and to examine the efficacy of paroxetine in the treatment of IBSExpand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 22 REFERENCES
Irritable bowel syndrome prevalence varies enormously depending on the employed diagnostic criteria: comparison of Rome II versus previous criteria in a general population.
TLDR
The prevalence of IBS varies enormously depending on the diagnostic criteria employed and, in particular, how this prevalence varies using the new Rome II criteria and previous diagnostic criteria is compared. Expand
The Functional Gastrointestinal Disorders: Diagnosis, Pathophysiology, and Treatment : A Multinational Consensus
TLDR
This book presents a single source of standardized definitions, diagnostic criteria and treatment recommendations forFunctional gastrointestinal disorders, which should no longer need to make a diagnosis of exclusion. Expand
Irritable bowel syndrome: definition, diagnosis and epidemiology.
  • N. Talley
  • Medicine
  • Bailliere's best practice & research. Clinical gastroenterology
  • 1999
TLDR
The development of acceptable, symptom-based diagnostic criteria has advanced the field, stimulating interest in the pathophysiology and targeted pharmacological therapy, which are essential steps if the disease burden is to be reduced. Expand
Irritable bowel syndrome in the general population.
TLDR
Symptoms consistent with a diagnosis of irritable bowel syndrome are present in almost one quarter of the general population and tend to be associated with a number of other complaints and conditions, some of which may reflect smooth muscle dysfunction. Expand
Impact of irritable bowel syndrome on quality of life
TLDR
The SF-36 may be a useful outcome measure in treatment studies, but investigators will need to correct for confounding influences of neuroticism. Expand
Irritable bowel syndrome according to varying diagnostic criteria: are the new Rome II criteria unnecessarily restrictive for research and practice?
TLDR
Having IBS regardless of which criteria were used was significantly associated with psychological morbidity, but psychological factors were not important in discriminating between diagnostic categories, and pain and bowel habit severity independently discriminated between diagnostic groups. Expand
Irritable bowel syndrome in general practice: prevalence, characteristics, and referral
TLDR
Half the patients with gut complaints seen by GPs have functional disorders, and few patients are referred, suggesting unconfident diagnosis or inadequate explanation. Expand
Medical costs in community subjects with irritable bowel syndrome.
TLDR
The economic impact of IBS is significant and a better understanding of the determinants of these costs is needed so that cost-saving strategies can be implemented. Expand
Clinical economics review: gastrointestinal disease in primary care.
  • R. Jones
  • Medicine
  • Alimentary pharmacology & therapeutics
  • 1996
TLDR
An exploration of the clinical economics of gastrointestinal disorders in general practice raises a number of research questions, which will require the attention of both generalists and specialists. Expand
The complexity of drug development for irritable bowel syndrome
  • M. Kamm
  • Medicine
  • Alimentary pharmacology & therapeutics
  • 2002
TLDR
The experience with serotonin modifying drugs has been mixed, and some important lessons are there to be learnt. Expand
...
1
2
3
...